Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Comment by TechnicalBuyon Dec 09, 2011 10:18am
234 Views
Post# 19306900

RE: ok, what gives

RE: ok, what givesFinally. The word is spreading I guess, and the price is appreciating in anticipation of Shire trial results. Bioasis conjugates compounds relatively quickly, so the trial results should be here within several months, if not the very next month.Your point about the price not correlating to news is well taken though. We are talking about a revolutionary product in the 100 bn annual sales cns market, yet not many investors have caught on. I think 10 bagger is just the start. Depnding on how things go, this company could be worth several gold mines put together.What I am really curious about is when will we see some of the smaller instituion analysts start to cover BTI. So far they've been unsure of the business model, but following the Shire news I bet most analysts are scratching their heads wondering if this is a hidden gem that would be perfect for their next writeup.Cheers,TB
Bullboard Posts